Investors & Media
LyGenesis’s cell therapies are engrafted using endoscopic ultrasound procedure, which is associated with decreased medical risks and costs relative to full organ transplantation. Our pipeline of therapies target a variety of unmet needs, including end stage liver disease, Type 1 diabetes, end stage renal disease, aging, and autoimmune disorder.
Grow Your Own Organs with Michael Hufford, LyGenesis
Host Dr. Nick van Terheyden aka Dr. Nick talks Grow Your Own Organs, with Michael Hufford, CEO Lygenesis. The discussion includes using the bodies own bio-reactor (lymph nodes) to grow replacement liver, recent FDA clearance to proceed to human trials, and how one donated liver could mean 70+ patients transplants.